阅读说明：本技术 一种治疗犬类湿疹的中成药 (Chinese patent medicine for treating dog eczema ) 是由 陈思琪 李洁 柴依璐 于 2019-11-29 设计创作，主要内容包括：本发明涉及一种治疗犬类湿疹的中成药,软膏包括以下原料成分：当归、白芍、川芎、生地黄、刺蒺藜、防风、荆芥穗、蝉蜕、地肤子、乌梢蛇、丹参、益母草和鸡血藤；油剂包括以下原料成分：紫草、橄榄油；喷雾包括以下原料成分：龙胆草、黄芩、栀子、丹皮、泽泻、车前草、苦参、薏苡仁、防风、大青叶、黄柏、地肤子和白鲜皮。该治疗犬类湿疹的中成药主要成分皆为中药,长期使用时病原微生物耐药性较小,成分安全,可减少药物对患处皮肤的刺激性,该治疗犬类湿疹的中成药通过中医辨证论治理论,将犬类基本皮肤病分症分型,以此为基础设计相应药物,使其治疗作用更具有针对性,增强对犬类个体不同性的区别治疗,以更好缓解症状,改善愈后。(The invention relates to a Chinese patent medicine for treating dog eczema, and an ointment comprises the following raw material components: chinese angelica, white paeony root, Szechuan lovage rhizome, raw rehmannia root, tribulus terrestris, divaricate saposhnikovia root, schizonepeta spike, cicada slough, broom cypress fruit, zaocys dhumnade, salvia miltiorrhiza, motherwort herb and suberect spatholobus stem; the oil agent comprises the following raw material components: lithospermum and olive oil; the spray comprises the following raw material components: radix Gentianae, Scutellariae radix, fructus Gardeniae, cortex moutan, Alismatis rhizoma, herba plantaginis, radix Sophorae Flavescentis, Coicis semen, radix Saposhnikoviae, folium Isatidis, cortex Phellodendri, Kochiae fructus and cortex Dictamni Radicis. The Chinese patent medicine for treating dog eczema is mainly prepared from traditional Chinese medicines, has small drug resistance of pathogenic microorganisms and safe components when being used for a long time, can reduce the irritation of the medicine to the skin of an affected part, divides the basic skin diseases of dogs into symptoms by the traditional Chinese medicine dialectical theory, designs corresponding medicines on the basis of the symptoms, has more pertinence on the treatment effect, enhances the different treatments on the dogs, better relieves symptoms and improves the healing.)

1. A Chinese patent medicine for treating dog eczema is characterized in that: comprises the following raw material components: angelica, white peony root, ligusticum wallichii, radix rehmanniae recen, tribulus terrestris, radix sileris, schizonepeta spike, cicada slough, fructus kochiae, zaocys dhumnade, salvia miltiorrhiza, motherwort and caulis spatholobi.

2. The Chinese patent medicine for treating canine eczema according to claim 1, which is characterized in that: the weight of the raw materials is as follows: 20g of angelica sinensis, 20g of radix paeoniae alba, 20g of ligusticum wallichii, 15g of radix rehmanniae recen, 15g of tribulus terrestris, 15g of radix saposhnikoviae, 15g of schizonepeta spike, 8g of cicada slough, 15g of fructus kochiae, 10g of zaocys dhumnade, 15g of salvia miltiorrhiza, 15g of leonurus and 20g of caulis spatholobi.

3. The Chinese patent medicine for treating canine eczema according to claim 1, which is characterized in that: the raw material processing steps are as follows: screening and weighing medicinal materials, grinding into powder with 250 meshes, extracting rapeseed oil, adding white vaseline and sodium potassium sorbate, and finally packaging.

Technical Field

The invention relates to the technical field of pet medicines, in particular to a Chinese patent medicine for treating dog eczema.

Background

The existing dog eczema treatment method mainly removes the causes of diseases, disinfects locally and treats the dog eczema by matching antibiotics with glucocorticoids, is limited in treatment method and poor in curative effect, and mainly comprises the following steps: 1. removing etiology and treating: -stimulating substances in the external environment: contacting dog body with anaphylactic substance, chemical, cement, grass, etc.; ② pathogen bite: bites by mosquitoes and ectoparasites; ③ the dogs seize themselves and lack of nutrition: supplying vitamins and trace elements; 2. using mucosal disinfectant for wound: cleaning rivanol, and then using cortical hormone ointment or matching with antibiotics; in more severe cases, clodronate chloride is selected; 3. for large area of severe inflammation, corticoids and antibiotics, such as Australian Baiyanpi kang-100, Australian Baiyanpi kang-50, Beijing Kangmu Pikang, American magic butter lotion, Simens mycogram-150, Vicker Payutuo injection or injection of antifungal I injection, are administered simultaneously.

However, the traditional antibiotic and hormone therapy mainly aims at relieving symptoms in the disease process of eczema, and is not suitable for conditioning and preventing diseases such as eczema, which are easy to relapse and prolong easily, the existing veterinary therapy means are single, more energy and time of dog caregivers need to be consumed by oral administration or injection of drugs, the compliance of dogs is not high, meanwhile, the domestic research of dog eczema therapy is few, most of the current-stage therapeutic drugs are imported abroad, the pet medical treatment is a new industry, the treatment cost is generally high, and therefore, a special Chinese patent medicine type external drug with good curative effect is needed to be provided for dog skin diseases, and the current situation that related products are lacked in the market is relieved.

Disclosure of Invention

The invention aims to provide a Chinese patent medicine for treating dog eczema, and aims to solve the problem that a special Chinese patent medicine external medicine with good curative effect for dog skin diseases is not provided in the market at present, wherein the problem is provided in the background technology.

In order to achieve the purpose, the invention provides the following technical scheme: a Chinese patent medicine for treating dog eczema comprises the following raw material components: angelica, white peony root, ligusticum wallichii, radix rehmanniae recen, tribulus terrestris, radix sileris, schizonepeta spike, cicada slough, fructus kochiae, zaocys dhumnade, salvia miltiorrhiza, motherwort and caulis spatholobi.

Preferably, the raw materials comprise the following components in parts by weight: 20g of angelica sinensis, 20g of radix paeoniae alba, 20g of ligusticum wallichii, 15g of radix rehmanniae recen, 15g of tribulus terrestris, 15g of radix saposhnikoviae, 15g of schizonepeta spike, 8g of cicada slough, 15g of fructus kochiae, 10g of zaocys dhumnade, 15g of salvia miltiorrhiza, 15g of leonurus and 20g of caulis spatholobi.

Preferably, the raw material processing steps are as follows: screening and weighing medicinal materials, grinding into powder with 250 meshes, extracting rapeseed oil, adding white vaseline and sodium potassium sorbate, and finally packaging.

Compared with the prior art, the invention has the beneficial effects that: the Chinese patent medicine for treating dog eczema comprises the main components of traditional Chinese medicines, has small drug resistance of pathogenic microorganisms and safe components when being used for a long time, can reduce the irritation of the medicine to the skin of an affected part, and is convenient and quick and appropriate in price due to the fact that Chinese patent medicine preparations such as paste and improved spray are adopted. The Chinese patent medicine for treating the canine eczema divides the basic skin diseases of the dogs into symptoms by the theory of treatment based on syndrome differentiation of traditional Chinese medicine, and designs corresponding medicines on the basis of the basic skin diseases, so that the treatment effect is more pertinent, and the traditional Chinese medicine treats acute eczema and chronic eczema by the syndrome differentiation of eczema local symptoms, such as: modified Gentiana Xiegan Tang and Bi Xie Yu Shuishi Tang are selected for acute and moist eczema; for chronic and dry eczema, four drugs of xiaofengyin are selected for modification, and are matched with the lithospermum oil; enhances the treatment of different types of individual dogs to better relieve symptoms and improve the recovery.

Detailed Description

The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the following embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.